Related Experiment Video
Updated: Jun 21, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities
Wen-Cheng Su1, Wei-Liang Liu, Ching-Wei Cheng
1Graduate Institute of Molecular Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan.
Abstract:
Cellular mechanisms involving the enhancement of interferon (IFN) signaling by ribavirin remain poorly understood. Here, we identified a novel role of ribavirin in the communication between p53 and the mammalian target of rapamycin (mTOR) signaling. Ribavirin activates p53 by stimulating mTOR and promoting the interaction between mTOR and p53. Activated p53 stimulates the transcription of IFN regulatory factor 9 and subsequently enhances IFN signaling. Furthermore, ribavirin-induced activation of mTOR and p53 enhances IFN-dependent signaling for the IFN-alpha/ribavirin combined treatment. We conclude that ribavirin enhances activities of mTOR and p53, which may account for its antiviral and antitumor effects.
Insights
Ribavirin enhances interferon signaling by activating p53 through mTOR. This discovery sheds light on ribavirin's antiviral and antitumor mechanisms.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Interferon (IFN) signaling is crucial for antiviral and antitumor responses.
- The precise mechanisms by which ribavirin enhances IFN signaling are not fully understood.
- Ribavirin is an established antiviral drug with known immunomodulatory effects.
Purpose of the Study:
- To elucidate the cellular mechanisms underlying ribavirin's enhancement of interferon signaling.
- To investigate the potential role of p53 and mTOR pathways in ribavirin's action.
- To explore how ribavirin affects the interplay between p53, mTOR, and IFN signaling.
Main Methods:
- Cellular assays to measure p53 and mTOR activation.
- Western blotting to assess protein-protein interactions (mTOR and p53).
- Quantitative PCR to analyze IFN regulatory factor 9 (IRF9) transcription.
- Interferon signaling pathway analysis in response to ribavirin and IFN-alpha treatment.
Main Results:
- Ribavirin was found to activate p53 by stimulating the mammalian target of rapamycin (mTOR) pathway.
- Ribavirin promotes the interaction between mTOR and p53.
- Activated p53, stimulated by ribavirin via mTOR, enhances the transcription of IFN regulatory factor 9 (IRF9).
- This leads to a subsequent enhancement of interferon signaling.
- Ribavirin-induced activation of mTOR and p53 amplifies IFN-dependent signaling, particularly in combination with IFN-alpha.
Conclusions:
- Ribavirin enhances interferon signaling through a novel mechanism involving the mTOR and p53 pathways.
- The activation of mTOR and p53 by ribavirin is a key factor in boosting IFN-dependent responses.
- These findings suggest that ribavirin's modulation of mTOR and p53 contributes to its observed antiviral and antitumor activities.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
PI3K/mTOR/AKT Signaling Pathway
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers

